UltraSight
Rehovot
About UltraSight
UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. UltraSight won the TCT 2020 Innovation Competition which took place during the Transcatheter Cardiovascular Therapeutics world conference. For mor information please visit us at www.ultrasight.com
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2024)
- Website: ultrasight.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device, mHealth, Software
Social Profiles
Canonical: https://fsome.com/organization/ultrasight-83033 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.